↓ Skip to main content

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis

Overview of attention for article published in Frontiers in endocrinology, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
39 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
Published in
Frontiers in endocrinology, December 2021
DOI 10.3389/fendo.2021.782118
Pubmed ID
Authors

Kaleen N. Hayes, Ulrike Baschant, Barbara Hauser, Andrea M. Burden, Elizabeth M. Winter

X Demographics

X Demographics

The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 7%
Professor 2 7%
Student > Master 2 7%
Student > Bachelor 1 4%
Student > Doctoral Student 1 4%
Other 4 15%
Unknown 15 56%
Readers by discipline Count As %
Medicine and Dentistry 6 22%
Immunology and Microbiology 2 7%
Business, Management and Accounting 1 4%
Nursing and Health Professions 1 4%
Computer Science 1 4%
Other 2 7%
Unknown 14 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2022.
All research outputs
#1,720,964
of 25,392,582 outputs
Outputs from Frontiers in endocrinology
#413
of 13,025 outputs
Outputs of similar age
#41,388
of 512,296 outputs
Outputs of similar age from Frontiers in endocrinology
#19
of 553 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,025 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 512,296 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 553 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.